Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no content or functionality was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedSite maintenance notes show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure (previous Revision: v3.3.2); no study details or data are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and displays Revision: v3.3.2. The previous wording about PubMed-derived publications has been replaced with updated phrasing.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the general operating status notice about government funding and NIH operations. This does not affect the study's core details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedCosmetic and layout changes are observed, with no changes to core study data such as title, status, enrollment, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check110 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational-status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference4%

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.